Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion type Assertion NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_head.
- NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion description "[To better understand the mechanism of resistance, we tested a panel of 16 small molecule inhibitors of different cellular signaling pathways, and identified TPCA-1 (IKK-? inhibitor) and ruxolitinib (JAK1/2 inhibitor), as strong enhancers of VSV-?M51 replication and virus-mediated oncolysis in all VSV-resistant PDAC cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_provenance.
- NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion evidence source_evidence_literature NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_provenance.
- NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion SIO_000772 26331681 NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_provenance.
- NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion wasDerivedFrom befree-2016 NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_provenance.
- NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_assertion wasGeneratedBy ECO_0000203 NP1293554.RASotFYvst3D0NJ4WXSC5tKfIEQf4cfbz_19AOS3mngmE130_provenance.